Address: Bozdechova 7, 150 00 Prague 5,Czech Republic
Tel: +420 2 2527 5600
Web: http://www.lundbeck.com/cz
Company description
Vision
Our vision is to become a world leader in psychiatry and neurology.
Mission
Our mission is to improve the quality of life of people suffering from psychiatric and neurological disorders.
Values
Imaginative – Dare to be different
‘Imaginative’ underlines a need to dare to be different. Lundbeck believes in the necessity of being open to new knowledge and alternative solutions. This is the cornerstone of Lundbeck’s value chain, from research and development to production, marketing and sales.
Passionate – Never give up
‘Passionate’ refers to a long-standing tradition of never giving up. Lundbeck has met with setbacks – and will meet them again – in the effort to find new treatments for CNS disorders.
Responsible – Do the right thing
‘Responsible’ means that Lundbeck employees are expected to do the right thing and act responsibly towards colleagues, the environment and the external community
Products and services
Lundbeck markets a number of different pharmaceuticals for the treatment of brain disorders. The most recently launched compounds include: Cipralex/Lexapro® (depression), Ebixa® (Alzheimer’s disease), Azilect® (Parkinson’s disease), Xenazine® (chorea associated with Huntington’s disease), Sabril® (epilepsy), Sycrest® (bipolar disorder) and OnfiTM (Lennox-Gastaut syndrome).